Symposium on clinical aspects in hepatitis virus infection. 5. Clinical practice of hepatitis: myocardial diseases, nephritis, and vasculitis associated with hepatitis virus.
Matsumori
A
A
The Department of Cardiovascular Medicine, Kyoto University, Graduate School of Medicine.
D000328:Adult; D000998:Antiviral Agents / Q000627:therapeutic use; D015415:Biomarkers; D009202:Cardiomyopathies / Q000139:chemically induced / Q000188:drug therapy / Q000453:epidemiology / Q000209:etiology*; D002311:Cardiomyopathy, Dilated / Q000453:epidemiology / Q000209:etiology / Q000821:virology; D002312:Cardiomyopathy, Hypertrophic / Q000453:epidemiology / Q000209:etiology / Q000821:virology; D002648:Child; D005260:Female; D005921:Glomerulonephritis / Q000453:epidemiology / Q000209:etiology* / Q000821:virology; D016174:Hepacivirus / Q000302:isolation & purification / Q000472:pathogenicity*; D006509:Hepatitis B / Q000150:complications*; D006515:Hepatitis B virus / Q000302:isolation & purification / Q000472:pathogenicity*; D006526:Hepatitis C / Q000150:complications*; D006801:Humans; D007372:Interferons / Q000627:therapeutic use; D007564:Japan / Q000453:epidemiology; D008297:Male; D015337:Multicenter Studies as Topic; D010488:Polyarteritis Nodosa / Q000453:epidemiology / Q000209:etiology* / Q000821:virology; D015995:Prevalence; D012367:RNA, Viral / Q000032:analysis
D000998:Antiviral Agents; D015415:Biomarkers; D012367:RNA, Viral; D007372:Interferons